4.7 Review

Guidelines for randomised controlled trials investigating Chinese herbal medicine

期刊

JOURNAL OF ETHNOPHARMACOLOGY
卷 140, 期 3, 页码 550-554

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.jep.2011.12.017

关键词

Clinical trials; Traditional Chinese medicine; Systems biology and omics; Quality traditional medicines

资金

  1. GP-TCM
  2. European Commission [223154]
  3. NIHR
  4. Rufford Maurice Laing Foundation
  5. National Institute for Health Research [PDF-2011-04-027] Funding Source: researchfish
  6. National Institutes of Health Research (NIHR) [PDF-2011-04-027] Funding Source: National Institutes of Health Research (NIHR)

向作者/读者索取更多资源

Ethnographic relevance: Clinical trials investigating Chinese herbal medicine (CHM) have been frequently criticised for their lack of scientific rigour. As part of the GP-TCM project a team of experienced clinical researchers and CHM practitioners have developed clinical trial guidelines for CHM that combine an appreciation for traditional methods of practice with detailed and practical advice on research methodology. Materials and methods: This paper presents an executive summary of this work. It introduces the practice of CHM and the key considerations that need to be addressed whilst researching this traditional medical system. Results: These guidelines emphasise the importance of identifying best practice, and then developing and applying appropriate and rigorous research methodologies to investigate CHM as a whole system. Conclusions: It is hoped that this will encourage a thoughtful and meticulous process of investigation that will clarify the contribution that CHM can make to our future healthcare. Innovative new approaches are considered including the application of the new omic technologies and systems biology as a way of enhancing our understanding of traditional practice (C) 2011 Elsevier Ireland Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据